baber/WOPTO huggingface dataset:
Patent AU-2010223114-A1 (AU)
Title: Chunks in gravy food compositions
Inventor: ANNIE WATELAIN
IPC: A23L35/00
Filed: 2010-03-10
Abstract: The invention provides chunks in gravy food compositions comprising chunks in gravy in a chunks to gravy ratio of from about 25:75 to about 60:40, wherein the gravy comprises from about 0.01 to about 1 % guar and from about 0.01 to about 1% deacetylated xanthan. The gravy maintains its viscosity during the manufacturing process and ensures an even distribution of the chunks in the chunks in gravy food composition.
Patent AU-2010243345-A1 (AU)
Title: Improvements in or relating to scanning ophthalmoscopes
Inventor: CURTIS GRAY DANIEL
IPC: A61B3/12
Filed: 2010-04-30
Abstract: The invention provides a scanning ophthalmoscope (10) for scanning the retina of an eye and method of operating the same. The scanning ophthalmoscope comprises a source of collimated light (12), a first scanning element (14) and a second scanning element (16). The source of collimated light (12) and the first and second scanning elements (14, 16) combine to provide a two-dimensional collimated light scan from an apparent point source. The scanning ophthalmoscope (10) further comprises a scan transfer device (20), wherein the scan transfer device (20) is a reflective element and has two foci and the apparent point source is provided at a first focus of the scan transfer device (20) and an eye (24) is accommodated at a second focus of the scan transfer device (20), and wherein the scan transfer device (20) transfers the two-dimensional collimated light scan from the apparent point source into the eye (24). The first and second scanning elements (14, 16) have operating parameters which are selected to control the direction of the two-dimensional collimated light scan from the apparent point source and/or adjust the dimensions of the two-dimensional collimated light scan from the apparent point source.
Patent AU-2010263353-A1 (AU)
Title: Biologically produced cyclic affinity tags
Inventor: TJIBBE BOSMA
IPC: C07K7/50
Filed: 2010-06-23
Abstract: The invention relates to novels ways of introducing an affinity tag into a protein of interest. Provided is an enzymatic method for providing a proteinaceous substance comprising a polypeptide of interest and a cyclic affinity tag, comprising the steps of: (a) providing at least one precursor proteinaceous substance, the precursor comprising said protein of interest and at least one motif of the general formula X1-Tag-X2, wherein X1 and X2 represent amino acids whose side chains can be linked enzymatically by a covalent bond; Tag is a short amino acid sequence capable of binding to a binding partner of the tag when cyclized; (b) contacting said precursor with at least one enzyme capable of forming a covalent bond between X1 and X2, thereby introducing an intramolecular ring structure comprising the Tag sequence; and (c) isolating the resulting cyclized proteinaceous substance. Also provided are proteinaceous substances obtainable thereby and the use thereof, for instance for preparing a peptide library.
Patent AU-2010264479-A1 (AU)
Title: Compounds and methods for treating influenza
Inventor: ROSSIGNOL JEAN-FRANCOIS
IPC: A61K31/425
Filed: 2010-06-23
Abstract: This invention is directed to methods for treating and preventing influenza infection by inhibiting influenza virus HA maturation processes employing compounds of formula I. It is also directed to combinations for treating and preventing influenza infection comprising compounds of formula I and other agents.
Patent AU-2010270359-A1 (AU)
Title: Process for the manufacture of halogenated precursors of alkenones under specific conditions
Inventor: BRAUN MAX
IPC: C07C49/175
Filed: 2010-07-05
Abstract: The invention relates to a process for preparing a halogenated precursor of an alkenone, which comprises reacting a carboxylic acid halide with a vinyl ether in a liquid reaction medium under turbulent conditions. The invention also relates to a process for preparing an alkenone, by eliminating hydrogen halide from said precursor to form the alkenone.
Patent AU-2010273253-A1 (AU)
Title: (+) - morphinans as antagonists of Toll-like receptor 9 and therapeutic uses thereof
Inventor: TRAWICK BOBBY N
IPC: A61K45/06
Filed: 2010-07-16
Abstract: The present invention provides (+)-morphinans comprising Toll-like receptor 9 (TLR9) antagonist activity, as well as a method for identifying (+)-morphinans that may be therapeutically effective by determining whether the (+)-morphinan inhibits the activation of TLR9. Also provided are methods of using the (+)-morphinans comprising TLR9 antagonist activity to treat conditions such as traumatic pain, neuropathic pain, inflammatory disorders, acetaminophen toxicity, autoimmune disorders, neurodegenerative disorders, and cancer.
Patent AU-2010275431-A1 (AU)
Title: Galantamine amino acid and peptide prodrugs and uses thereof
Inventor: FRANKLIN RICHARD
IPC: A61P25/28
Filed: 2010-07-23
Abstract: Prodrugs of galantamine or its 3-hydroxy metabolite with amino acids or short peptides, pharmaceutical compositions containing such prodrugs and methods for treating a memory or cognition disorder with the galantamine prodrugs are provided herein. Prodrugs having side chains of valine, phenylalanine, tyrosine or para amino benzoic acid and mono-, di- and tripeptides thereof are preferred. Additionally, methods for avoiding or minimizing the adverse gastrointestinal side effects associated with galantamine administration, as well as improving the pharmacokinetics of galantamine are provided herein.
Patent AU-2010288663-A1 (AU)
Title: Velocity factor
Inventor: SCHRAEML MICHAEL
IPC: C07K16/00
Filed: 2010-08-19
Abstract: The current invention is directed to the velocity factor. Based on the velocity factor antibodies can be classified, i.e. antibodies can be characterized on their binding properties as e.g. entropic or enthalpic antigen binder. A velocity factor based classification does not require detailed thermodynamic determinations and/or calculations. The velocity factor is the ratio of the antigen-antibody complex association rate constants ka determined at 37 °C and 13 °C. As only two experimental determinations are required to calculate the velocity factor this is a fast and high-throughput suited method.
Patent AU-2010315101-A1 (AU)
Title: Methods for affinity maturation-based antibody optimization
Inventor: SMIDER VAUGHN
IPC: C07K16/28
Filed: 2010-11-04
Abstract: Provided herein is a rational method of affinity maturation to evolve the activity of an antibody or portion thereof based on the structure/affinity or activity relationship of an antibody. The resulting affinity matured antibodies exhibit improved or optimized binding affinity for a target antigen.
Patent AU-2010332507-A1 (AU)
Title: Resonance engine
Inventor: GREENYER GUY THOMAS
IPC: B64C39/02
Filed: 2010-12-15
Abstract: A resonance engine is disclosed comprising: a driver plate (12), to which is coupled at least one oscillatory transducer (14); a drive signal generator connected to the oscillatory transducer for excitation thereof; a first spring-mass resonator, having a first natural resonant frequency, with a proximal end attached to the driver plate (12) and a free distal end; and a reaction means attached to the driver plate substantially opposite to the first spring-mass resonator. When the oscillatory transducer (14) is excited by a drive signal from the generator having a component at or close to said natural resonant frequency, the first spring-mass resonator oscillates at resonance, substantially in anti -phase to the driver plate (12). Small vibrational strains in the oscillatory transducer (14) are converted to large strains of controllable kinematic movements.
Patent AU-2010335966-A1 (AU)
Title: Wireless power transmission using phased array antennae
Inventor: VIGLIONE LOUIS
IPC: H01Q3/30
Filed: 2010-12-10
Abstract: A remote device powering module, system and method for providing RF power to an electronic device located in a bounded area. The remote device powering module comprises a phased array antenna and is connected to a source to convert the power to an electric signal and to apply a phase reference to the electrical signal. The electrical signal is shifted with a shifting module and phased array antenna that comprises a plurality of radiating elements generates and transmits RF power via RF waves using the phase reference and the shifted phase. The RF power is then converted by the receiver to direct-voltage to be provided to the electronic device.
Patent AU-2011201106-A1 (AU)
Title: Enhanced coding and parameter representation of multichannel downmixed object coding
Inventor: ENGDEGARD JONAS
IPC: G10L19/00
Filed: 2011-03-11
Abstract: An audio object coder for generating an encoded object signal using a plurality of audio objects includes a downmix information generator for generating downmix information indicating a distribution of the plurality of audio objects into at least two downmix channels, an audio object parameter generator for generating object parameters for the audio objects, and an output interface for generating the imported audio output signal using the downmix information and the object parameters. An audio synthesizer uses the downmix information for generating output data usable for creating a plurality of output channels of the predefined audio output configuration.
Patent AU-2011201904-A1 (AU)
Title: Disposal of Human Remains
Inventor: SULLIVAN ALEXANDER
IPC: B09B3/00
Filed: 2011-04-28
Abstract: A coffin (130) for use in an alkaline hydrolysis process, the coffin comprising a dissolvable receptacle for a cadaver, the dissolvable receptacle being dissolvable in the alkaline hydrolysis process.
Patent AU-2011204983-A1 (AU)
Title: Window assembly
Inventor: NAHMIAS ROY
IPC: F41H5/26
Filed: 2011-07-26
Abstract: An armored assembly constituting a part of a structure having an interior. The assembly comprises a wall having an inner surface and an outer surface, wherein 5 the wall is formed with an opening extending between the inner surface and the outer surface. The opening has a rim area surrounding the opening. The assembly further comprises a window having a frame sized and shaped so as to externally cover the opening and the rim area and a 10 pane fitted within the frame. The window is attached to the outer surface of the wall in a displaceable manner. The assembly also comprises a drive mechanism including a motor located so as to be spaced from the outer surface of the wall by its inner surface, and a drive member 15 connected to the motor and configured to be operated thereby. The drive member is at least partially protruding from the outer surface of the wall in the direction away from its inner surface. The assembly also has a driven member attached to the window, the driven member being 20 disposed between the frame and the wall. The driven member is configured for engagement with the drive member such as to displace the window and thereby expose exterior of the structure to its interior via at least a portion of the opening. 2755148_1 (GHMatters) P87710.AU 26/07/11 co 0, eCN e5, a .u.
Patent AU-2011211333-A1 (AU)
Title: Systems and methods for removing finely dispersed particulate matter from a fluid stream
Inventor: DAVID SOANE
IPC: C02F1/56
Filed: 2011-08-10
Abstract: Disclosed herein are systems for removing particulate matter from a fluid, comprising a particle functionalized by attachment of at least one activating group or amine functional group, wherein the modified particle complexes with the particulate matter within the fluid to form a removable complex therein. The particulate matter has preferably been contacted, complexed or reacted with a tethering agent. The system is particularly advantageous to removing particulate matter from a tailing solution.
Patent AU-2011213804-A1 (AU)
Title: Tamper resistant oral pharmaceutical dosage forms comprising an opioid analgesic
Inventor: OWEN MANNION RICHARD
IPC: A61K31/485
Filed: 2011-08-19
Abstract: TAMPER RESISTANT ORAL PHARMACEUTICAL DOSAGE FORMS COMPRISING AN OPIOID ANALGESIC Abstract The present invention relates to pharmaceutical dosage. forms, for example to a 5 tamper resistant dosage form including an opioid analgesic, and processes of manufacture, uses, and methods of treatment thereof.
Patent AU-2011215823-A1 (AU)
Title: Method and system for optimizing film production and minimizing film scrap
Inventor: BOGUE BEUFORD A
IPC: G06F19/00
Filed: 2011-02-10
Abstract: The present invention relates to a method of optimizing self-supporting film production which includes the steps of: determining at least one scrap factor which relates to a total amount of scrap in processing a film product; correlating the at least one scrap factor to at least one processing parameter; and adjusting the at least one processing parameter to reduce the total amount of scrap in processing the film product.
Patent AU-2011238427-A1 (AU)
Title: Monitoring device
Inventor: HAUSLER TIM
IPC: C25D21/12
Filed: 2011-04-07
Abstract: A monitoring device comprising sensing means adapted to measure one or more operational parameters of at least one electrode in an electrowinning or electrorefining cell, transmission means adapted to transmit information about the one or more operational parameters and retention means adapted to retain the monitoring device on the at least one electrode.
Patent AU-2011244850-A1 (AU)
Title: Cotton variety P07X.8212.RF
Inventor: ANDERSON DAVID M
IPC: A01H5/10
Filed: 2011-10-28
Abstract: Abstract of the Disclosure A cotton variety, designated P07X.8212.RF, the plants and seeds of the cotton variety P07X.8212.RF, methods for producing a cotton plant, either varietal or hybrid, produced by crossing the cotton variety P07X.8212.RF with itself or with another cotton plant, and hybrid cotton seeds and plants produced by crossing the variety PO7X.8212.RF with another cotton variety or plant and to methods for producing a cotton plant containing in its genetic material one or more transgenes and to the transgenic cotton plants produced by that method. This disclosure also relates to cotton varieties derived from cotton variety P07X.8212.RF, to methods for producing other cotton varieties derived from cotton variety P07X.8212.RF, and to the varieties derived by the use of those methods.
Patent AU-2011250139-A1 (AU)
Title: Chitosan composition
Inventor: ANDERSSON MATS
IPC: A23L33/15
Filed: 2011-04-15
Abstract: This invention provides a composition comprising: (i) a chitosan hydrogel comprising cross-linked chitosan and water; and (ii) a liquid dispersed in the hydrogel.
Patent AU-2011269819-A1 (AU)
Title: Catheter assembly with seal member
Inventor: GORAL DAVID J
IPC: A61M39/06
Filed: 2011-04-25
Abstract: A catheter assembly includes a catheter hub (12) defining an interior cavity (24) and a catheter tube (14) extending distally thereof. A rigid actuator (16) extends proximally in the interior cavity (24) and supports a seal member (18) thereon. The seal member (18) includes a central membrane (72), a distal portion (74), and a proximal portion (76). An hourglass shaped actuator cavity (88) is formed in the distal portion (74) and receives a barbed end (50) of the actuator (16). The outer surface (71) of the seal member (18) is in partial circumferential engagement with the catheter hub (12) to define an air path (102) that allows fluid communication between areas (PI and Dl) of the interior cavity (24) distal and proximal of the seal member (18). A punch tool (160) is provided to form a tri-slit (82) in the membrane (72) of the seal member (18). The seal member (18) may be configured for multi-use and include a biasing member (204) that moves the seal member (18) to force the membrane (72) back over the actuator (16) to close the membrane (72).
Patent AU-2011284562-A1 (AU)
Title: Ophthalmic device molds formed from highly amorphous vinyl alcohol polymer, ophthalmic devices molded therein, and related methods
Inventor: GOODENOUGH NEIL
IPC: G02B1/04
Filed: 2011-06-13
Abstract: Ophthalmic device molds made from at least one highly amorphous vinyl alcohol polymer, ophthalmic devices such as ocular inserts and contact lenses and including silicone hydrogel devices formed using these molds, and related methods are described. The methods of manufacturing ophthalmic devices can use dry or wet demolding processes, or dry or wet delensing processes.
Patent AU-2011306696-A1 (AU)
Title: Pressure vessel
Inventor: LIEBENBERG ADRIENNE
IPC: B62B1/12
Filed: 2011-09-15
Abstract: A pressure vessel (1) is described comprising an inner fibre-wound pressure vessel (5), a jacket (3), a lid (17) and a wheel base (9). The wheel base (9) comprises a main body (1 1 ) having an open end for receiving the base of the jacket (3); a releasable catch (85) operable to attach the main body (11) of the wheel base (9) to a casing (3) mounted on the main body (11) of the wheel base (9) when the base (76) of jacket (3) is inserted into the open end of the wheel base (9); and wheels rotatably (13) attached to the main body (11) of the wheel base (9). When the jacket (3) is mounted to the wheel base (9), the casing (5) and the wheel base (9) are operable to be transferred between locations using the lid (17) and the wheels (13).
Patent AU-2011320007-A1 (AU)
Title: Electronic device in plastic
Inventor: THIEL DAVID
IPC: H01L27/12
Filed: 2011-10-07
Abstract: The invention concerns a method for forming an electronic device in plastic. The method for forming an electronic device in plastic comprises: (a) placing electronic components (220, 215) in recesses (210, 215) in a thermoplastic substrate (200); (b) depositing (135) an electronic circuit (230) over the electronic components (220, 225), or onto a thermoplastic sheet (240); and (c) bonding (160) the thermoplastic substrate (200) with the thermoplastic sheet (240) in a thermal bonding process to seal the electronic components (220, 215) and the electronic circuit (230) between the thermoplastic substrate (200) and the thermoplastic sheet (240), wherein the method further comprises providing a thermally conductive layer (250) on the thermoplastic sheet (240) and/or substrate (200) such that heat applied during the thermal bonding process is distributed uniformly across the thermoplastic sheet (240) and/or substrate (200) to facilitate bonding of the thermoplastic sheet (240) and substrate (200). In another aspect, the invention concerns an electronic device formed according to the method. It is an advantage that a more uniform heat distribution is achieved.
Patent AU-2011340685-A1 (AU)
Title: Triazolopyridine compounds
Inventor: FLOHR ALEXANDER
IPC: A61P25/00
Filed: 2011-12-05
Abstract: The invention is concerned with triazolopyridine compounds of formula (I), wherein R
Patent WO-2013006918-A1 (WO)
Title: Procédés cryptographiques
Inventor: LOCKE SIMON
IPC: H04L9/32
Filed: 2012-07-13
Abstract: La présente invention se rapporte à un procédé selon lequel, dans un réseau de communication, une clé publique d'un premier nœud est envoyée à un second nœud. Le procédé selon l'invention consiste : à appliquer une fonction de chiffrement unidirectionnelle sur la clé publique et sur des premières données d'image en provenance du premier nœud, dans le but de générer des premières données condensées; à envoyer les premières données condensées au second nœud; à recevoir une confirmation selon laquelle les premières données condensées ont été reçues par le second nœud; à envoyer la clé publique et les premières données d'image au second nœud, de manière à permettre au second nœud de déterminer que la clé publique et les premières données d'image ont été utilisées afin de générer les premières données condensées; et à envoyer des secondes données d'image au second nœud, de manière à permettre au second nœud de déterminer que les secondes données d'image sont cohérentes avec les premières données d'image et, par voie de conséquence, que la clé publique qui a été reçue par le second nœud correspond bien à la clé publique du premier nœud.
Patent AU-2012201642-A1 (AU)
Title: Receiver and method
Inventor: LOVELL MARTIN
IPC: H04J11/00
Filed: 2012-03-20
Abstract: RECEIVER AND METHOD Abstract 5 A receiver receives. data from a sequence of OFDM symbols (126) transmitted via a channel, each OFDM symbol comprising a plurality of data bearing sub-carriers on which the data is transmitted and a plurality of pilot bearing sub-carriers on which pilot data symbols are transmitted. The pilot sub-carriers are arranged within the OFDM symbols in accordance with a predetermined pilot sub-carrier pattern. The 0 receiver includes a channel estimator (300) for estimating the channel and an equaliser for reducing the effects of the channel so that the data can be recovered from the received OFDM symbols. The channel estimator includes a notch processor (310) which is arranged in operation to detect a notch (268) in a received OFDM symbol, the notch providing a plurality of the sub-carriers of the received OFDM symbol within a 15 frequency range which were not transmitted by the transmitter, to determine one or more missing pilot sub-carriers which would have been transmitted within the notch sub-carriers of OFDM symbols according to the pilot sub-carrier pattern, and to generate orle or more replacement pilot data symbol for a missing pilot data sub carrier, which would have been transmitted according to the predetermined pattern but 20 was not transmitted as a. result of the notch, from one or more other pilot sub-carriers which have been receive within OFDM symbols which are not within the notch. The channel estimator can therefore be arranged to recover an estimate of the channel even though the presence of the notch causes one or more of the sub-carriers of the pilot pattern to be missing, which has a greater accuracy than could be achieved without the 25 missing pilot sub-carriers. An improvement in the likelihood of correctly recovering the data is thereby achieved. 6120754-1 o A) = o 0 o 00 x 0 i~ jL Ol C
Patent AU-2012202000-A1 (AU)
Title: Combination therapies using HDAC inhibitors
Inventor: LICHENSTEIN HENRI
IPC: A61K31/282
Filed: 2012-04-05
Abstract: The present invention pertains to a method for treating cancer, such as lung cancer, multiple myeloma, lymphoma, and epithelial ovarian cancer, comprising 5 the administration to a patient in need thereof a first amount or dose of a histone deacetylase (HDAC) inhibitor, such as PXD-101, and a second amount or dose of another chemotherapeutic agent, such as dexamethasone or 5-fluorouracil, or an epidermal growth factor receptor (EGFR) inhibitor, such as Tarceva@, wherein the first and second amounts or doses together comprise a therapeutically effective 10 amount.
Patent AU-2012202610-A1 (AU)
Title: Image display device and autostereoscopic panel
Inventor: TSUTSUI MASANAO
IPC: G02B30/27
Filed: 2012-05-03
Abstract: An information processing apparatus that determines whether an autostereoscopic panel is attached to a display, and controls the display to display a two-dimensional (2D) image or three-dimensional (3D) image based on the determination. 3330761_1 (GHMatter) P90275.AU 3-May-12 22b22 22a 33a 3 33 1b 1d 1c 1bal b 4e FIG. 1 B 100 3 22b 33a '-----22a 33b -21 1 b 1 d 1 c 1b4 l b 4 1e 1